Practice-changing trials on breast cancer.

Autor: Kirova Y; Department of Radiation Oncology, Institut Curie, Paris, France. Electronic address: youlia.kirova@curie.fr., Bouziane J; Department of Radiation Oncology, Institut Curie, Paris, France., Loap P; Department of Radiation Oncology, Institut Curie, Paris, France.
Jazyk: angličtina
Zdroj: Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2024 Nov; Vol. 28 (6-7), pp. 510-512. Date of Electronic Publication: 2024 Sep 27.
DOI: 10.1016/j.canrad.2024.07.004
Abstrakt: There is new data in the fractionation modalities and these are the really the practice-changing trials of last years: can we use hypo fractionated whole breast radiotherapy in patients presented with ductal carcinoma in situ? Can we realize hypofractionated whole breast radiotherapy with simultaneous integrated boost? What about hypofractionated irradiation after mastectomy with reconstruction? Can we do hypofractionation to lymph nodes without risk of increased toxicity? The purpose of this work is to respond with the last evidence-based recently presented or published data.
(Copyright © 2024 Société française de radiothérapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: